E‐5842:一种新的有效和优先的Sigma配体。临床前药理概况

{"title":"E‐5842:一种新的有效和优先的Sigma配体。临床前药理概况","authors":"X. Guitart, X. Codony, M. Ballarín, A. Dordal, A. Farré","doi":"10.1111/J.1527-3458.1998.TB00065.X","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10499,"journal":{"name":"CNS drug reviews","volume":"19 7","pages":"201-224"},"PeriodicalIF":0.0000,"publicationDate":"1998-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"29","resultStr":"{\"title\":\"E‐5842: A New Potent and Preferential Sigma Ligand. Preclinical Pharmacological Profile\",\"authors\":\"X. Guitart, X. Codony, M. Ballarín, A. Dordal, A. Farré\",\"doi\":\"10.1111/J.1527-3458.1998.TB00065.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10499,\"journal\":{\"name\":\"CNS drug reviews\",\"volume\":\"19 7\",\"pages\":\"201-224\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"29\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS drug reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1527-3458.1998.TB00065.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drug reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1527-3458.1998.TB00065.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}